Effects of Pentoxifylline on Non-Alcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial in Iran

BACKGROUND: Non-alcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease. Several studies suggest that pentoxifylline (PTX) can improve the disease outcome. OBJECTIVES: We aimed to compare the effect of pentoxifylline with placebo on liver aminotransferases and cyto...

Descripción completa

Detalles Bibliográficos
Autores principales: Baniasadi, Nadieh, Salajegheh, Faranak, Pardakhty, Abbas, Seyedmirzaee, Seyed Mehdi, Hayatbakhsh, Mohammad Mahdi, Nikpoor, Amin Reza, Mohammadi, Mojgan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719129/
https://www.ncbi.nlm.nih.gov/pubmed/26834792
http://dx.doi.org/10.5812/hepatmon.32418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719129/
https://www.ncbi.nlm.nih.gov/pubmed/26834792
http://dx.doi.org/10.5812/hepatmon.32418

Ejemplares similares